Indian Pricing Authority Intent On Recovering Funds From Drug Companies That Allegedly Overcharged Consumers
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's drug price regulator, the National Pharmaceutical Pricing Authority, which monitors and fixes drug prices and their availability in India, has accelerated its efforts to recover $411 million that drug manufacturers have allegedly overcharged consumers for controlled drugs in the last 12 years